UnitedHealth raised its 2026 outlook. UnitedHealth Group stock gains 1.70 percent

Published on 10/20/2026 at 10:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 earnings hit USD 4.69 versus USD 4.14 estimates. UnitedHealth Group stock costs EUR 364.70 on October 20, 2026, 1.70 percent above Xetra close.

Guidance and cost control

UnitedHealth raised adjusted 2026 earnings guidance to at least USD 20.50 on October 13, 2026.
The third-quarter medical care ratio was 88.40 percent versus 89.90 percent a year earlier.
UnitedHealth Group stock trades at EUR 364.70 at 10:30 a.m. CEST at Lang & Schwarz on October 20, 2026, 1.70 percent above the Xetra close of October 19, 2026.
JPMorgan raised its target from USD 516.00 to USD 524.00 on October 16, 2026.

Redaktionelles Börsenparkettfoto mit grünen Kursbildschirmen, Händlern und dynamischer Handelsatmosphäre — UnitedHealth Group US91324P1021 am NYSE-Börsenparkett mit grünen Healthcare-Kurscharts und sehr aktiven Börsenhändlern, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) was trading at EUR 364.70 at Lang & Schwarz on October 20, 2026 at 10:30 a.m. CEST, 1.70 percent above the Xetra close of October 19, 2026 at EUR 358.60. On October 13, 2026, UnitedHealth Group raised its adjusted 2026 earnings outlook to at least USD 20.50 per share after reporting third-quarter results.

Guidance improves after earnings beat

The third-quarter numbers gave the revised outlook a concrete foundation. Revenue reached USD 112.70 billion for the three months ended September 30, 2026, while earnings from operations were USD 6.60 billion and net margin was 3.60 percent, according to the company release.

Adjusted earnings per share came to USD 4.69, compared with USD 4.14 expected, while revenue exceeded the USD 111.40 billion consensus estimate, CNBC reported on October 13, 2026. Adjusted earnings per share also rose from USD 2.92 a year earlier, according to Reuters.

Three milestones frame the recovery

UnitedHealth's recent sequence shows how the repair has developed. On June 3, 2026, the quarterly dividend was raised to USD 2.32 per share; on July 16, second-quarter revenue reached USD 112.03 billion; and on October 13, third-quarter revenue reached USD 112.70 billion while adjusted guidance reached at least USD 20.50. The dividend and second-quarter figures are reported by Moat Explorer, while the latest figures come from the company release.

What do medical costs mean for margins?

The medical care ratio was 88.40 percent in the third quarter, down from 89.90 percent a year earlier. That improvement supports the higher outlook, but management also said medical costs remain elevated, keeping the ratio a central test for the recovery, CNBC reported.

Analyst target and reporting date

JPMorgan raised its UnitedHealth target from USD 516.00 to USD 524.00 on October 16, 2026, while maintaining an overweight rating, according to MarketBeat. The next earnings date is listed as January 25, 2027, by FinDog.

Stock price and operating test

The company operates across UnitedHealthcare and Optum and is listed on the NYSE under ticker UNH. Its market capitalization was USD 365.2 billion as of October 20, 2026, while its balance-sheet debt stood at USD 74.33 billion at September 30, 2026. UnitedHealth Group stock was trading at EUR 364.70 at Lang & Schwarz on October 20, 2026 at 10:30 a.m. CEST, 1.70 percent above the Xetra close of October 19, 2026 at EUR 358.60. The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.